Near-Infrared-Responsive Choline-Calix[4]arene-Gold Nanostructures for Potential Photothermal Cancer Treatment
Source abstract
Abstract
The development of novel chemical approaches for the fabrication of gold nanostructures with localized surface plasmon resonance (LSPR) falling in the near-infrared (NIR) region is one challenging topic in nanomaterials science. Due to their optical and photothermal properties triggered by light excitation in the therapeutic window (Amax = 650-1300 nm), gold-based nanostructures are appealing candidates in anticancer nanomedicine. Here, we report a novel method to prepare waterdispersible gold nanostructures with NIR-LSPR (Amax = 600-1000 nm) properties. The gold nanostructures were achieved in a single step by an unconventional method using NADH as a reducing agent and an amphiphilic choline-calix[4]arene derivative (CholCalix) forming micelles as a template. The CholCalix-Au nanostructures were characterized by UV-visible spectrophotometry, Raman spectroscopy, and atomic force microscopy. Agglomeration of the nanostructures due to multiple crosslinking interactions was observed and supported by modeling simulation. Effective anticancer photothermal-induced effect of the CholCalix-AuNPs was demonstrated on human breast cancer cells irradiated with biofriendly light at 808 nm.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CNR-Institute of Biomolecular Chemistry, Via Paolo Gaifami 18, 95126Catania, Italy
CIB-Interuniversity Consortium for Biotechnologies U.O. of Catania, Via Flavia, 23/1, 34148Trieste, Italy
Department of Drug Science and Health, University of Catania, Via Santa Sofia 64, 95125Catania, Italy
Dipartimento di Fisica e Chimica, University of Palermo, Via Archirafi n. 36, Palermo90133, Italy
ST-Lab srl, 95126Catania, Italy
Funding
Universit? di Catania
References (67)
Show source-provided references
1. 10.3390/biom1206078410.3390/biom12060784 ↗
2. 10.3390/jpm1108077110.3390/jpm11080771 ↗
3. 10.1016/j.cca.2014.05.00410.1016/j.cca.2014.05.004 ↗
4. 10.1080/1061186X.2018.151902910.1080/1061186X.2018.1519029 ↗
5. 10.1186/s12951-021-01080-310.1186/s12951-021-01080-3 ↗
6. 10.1016/j.matdes.2022.11039110.1016/j.matdes.2022.110391 ↗
7. 10.1039/C9CC05727G10.1039/C9CC05727G ↗
8. 10.1186/s12951-021-01124-810.1186/s12951-021-01124-8 ↗
9. 10.1016/j.colsurfb.2021.11165410.1016/j.colsurfb.2021.111654 ↗
10. 10.3390/jnt302000810.3390/jnt3020008 ↗
11. 10.1016/j.apmt.2021.10100310.1016/j.apmt.2021.101003 ↗
12. 10.1002/wnan.144910.1002/wnan.1449 ↗
13. 10.3389/fchem.2019.0016710.3389/fchem.2019.00167 ↗
14. 10.1039/D0NA00472C10.1039/D0NA00472C ↗
15. 10.1016/j.biomaterials.2011.10.05810.1016/j.biomaterials.2011.10.058 ↗
16. 10.1016/j.sbsr.2016.04.00210.1016/j.sbsr.2016.04.002 ↗
17. 10.1021/acs.langmuir.7b0262010.1021/acs.langmuir.7b02620 ↗
18. 10.3390/pharmaceutics1401007010.3390/pharmaceutics14010070 ↗
19. 10.1002/anie.20191638010.1002/anie.201916380 ↗
20. 10.2147/DDDT.S8321310.2147/DDDT.S83213 ↗
21. 10.1002/sstr.20220006710.1002/sstr.202200067 ↗
22. 10.1007/s12274-022-4332-410.1007/s12274-022-4332-4 ↗
23. 10.1021/acsami.0c2174310.1021/acsami.0c21743 ↗
24. 10.1039/C6OB01305H10.1039/C6OB01305H ↗
25. 10.1021/jacs.0c0687210.1021/jacs.0c06872 ↗
26. 10.7150/thno.6703610.7150/thno.67036 ↗
27. 10.1039/C9SM01795J10.1039/C9SM01795J ↗
28. 10.1021/acs.bioconjchem.0c0066910.1021/acs.bioconjchem.0c00669 ↗
29. 10.1007/s41061-016-0029-z10.1007/s41061-016-0029-z ↗
30. 10.1021/jp105143p10.1021/jp105143p ↗
31. 10.1039/C4CC03159H10.1039/C4CC03159H ↗
32. 10.1021/jp808165f10.1021/jp808165f ↗
33. 10.1021/acs.langmuir.7b0214010.1021/acs.langmuir.7b02140 ↗
34. 10.1016/j.arabjc.2019.04.00710.1016/j.arabjc.2019.04.007 ↗
35. 10.1007/s00396005032110.1007/s003960050321 ↗
36. 10.1021/la403377a10.1021/la403377a ↗
37. 10.1039/C4NJ01395F10.1039/C4NJ01395F ↗
38. 10.1021/acs.molpharmaceut.6b0106610.1021/acs.molpharmaceut.6b01066 ↗
39. 10.1016/j.msec.2020.11084210.1016/j.msec.2020.110842 ↗
40. 10.2310/7290.2006.0003210.2310/7290.2006.00032 ↗
41. 10.25011/cim.v36i3.1972410.25011/cim.v36i3.19724 ↗
42. 10.19185/matters.20170500000710.19185/matters.201705000007 ↗
43. 10.1039/b506608e10.1039/b506608e ↗
44. 10.1039/c2ra20491f10.1039/c2ra20491f ↗
45. 10.1016/j.softx.2015.06.00110.1016/j.softx.2015.06.001 ↗
46. 10.1021/ja962176010.1021/ja9621760 ↗
47. 10.1016/j.comptc.2015.05.01410.1016/j.comptc.2015.05.014 ↗
48. 10.1039/C5CC01032B10.1039/C5CC01032B ↗
49. 10.1039/c2jm16118d10.1039/c2jm16118d ↗
50. 10.1017/S143192761200999310.1017/S1431927612009993 ↗
51. 10.1088/0957-4484/19/11/11560710.1088/0957-4484/19/11/115607 ↗
52. 10.1016/j.ultsonch.2017.12.04210.1016/j.ultsonch.2017.12.042 ↗
53. 10.1016/j.bios.2009.04.00610.1016/j.bios.2009.04.006 ↗
54. 10.3389/fchem.2020.62646710.3389/fchem.2020.626467 ↗
55. Sakurai, H.; Mitsuharu, K.Preparation of metal nanoparticles using shell-crosslinked micelle as template. JP2003147418A, 2008.
56. 10.1039/D1PY01180D10.1039/D1PY01180D ↗
57. 10.1515/cclm.2011.73210.1515/cclm.2011.732 ↗
58. 10.1126/science.124739010.1126/science.1247390 ↗
59. 10.1038/nmat216210.1038/nmat2162 ↗
60. 10.5012/bkcs.2014.35.8.256710.5012/bkcs.2014.35.8.2567 ↗
61. 10.1002/cphc.20120017510.1002/cphc.201200175 ↗
62. 10.1021/la903186510.1021/la9031865 ↗
63. 10.3389/fmolb.2021.69179510.3389/fmolb.2021.691795 ↗
64. 10.1007/s10853-022-07868-410.1007/s10853-022-07868-4 ↗
65. Blanco, R.; Bondì, M. L.; Cavallaro, G.; Consoli, G. M. L.Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases. WO055976, 2016.
66. 10.3390/ijms2114505310.3390/ijms21145053 ↗
67. 10.1016/j.matpr.2020.12.82610.1016/j.matpr.2020.12.826 ↗